$326.45
+3.76 (+1.17%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Price Target
Analyst Price Target
-73.4% upside
Low Target
$54.31
Average Target
$86.77
High Target
$114.95
Current Price
$326.45
Current
$326.45
$326.45
Target
$86.77
$86.77
$54.31
$86.77 avg
$114.95
Scenario Analysis
Bear Case
$54.31
-83.4%
Low target
Base Case
$86.77
-73.4%
Avg target
Bull Case
$114.95
+-64.8%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$382.54
-14.7% from high
52-Week Low
$132.31
+146.7% from low
50-Day SMA
$263.07
+24.1% vs SMA
200-Day SMA
$186.47
+75.1% vs SMA
RSI (14)
38.4
Neutral
Target vs 52W High
$86.77
-77.3% vs high
Next Earnings Report
Aug 10, 2026 · Before Market Open
1d
tomorrow
EPS Est: $1.75
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 79% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -11.6% |
| REGN | Buy | 38 | 71% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 44 | 64% | $91.45 | -56.0% |